Analyst firms · BofA Securities · RXST

BofA Securities RXST price target and rating history

RxSight Inc. (RXST) · Health Care

BofA Securities rates RxSight Inc. (RXST) Underperform with a $22 price target, as of its latest action on Apr 3, 2025. It has published 3 rating actions on RXST since August 2021, including 0 upgrades and 1 downgrade.

Current rating
Underperform
Price target
$22
Median target, all firms
Too few
Actions on RXST
3

BofA Securities price target on RXST

$51$37$2220222023202420252026
BofA Securities price target on RXST, each point a stated target, August 2021 to April 2025. Targets before April 2025 (multiplied by 3) are adjusted for a stock split, going by the prior target BofA Securities restated.

Every BofA Securities rating on RXST

Questions about BofA Securities and RXST

What is BofA Securities's price target for RXST?
BofA Securities's latest stated price target for RxSight Inc. (RXST) is $22, from its action on Apr 3, 2025.
What is BofA Securities's rating on RXST?
BofA Securities rates RXST Underperform, a bearish rating, as of Apr 3, 2025.
When did BofA Securities last change its view on RXST?
On Apr 3, 2025, BofA Securities downgrades to Underperform from Buy, price target $36 to $22.

More RXST rating histories

All BofA Securities ratingsRXST news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.